Hernani Robin

Statistics

Publications

Citations

H-Index

Active since

1997

Affiliations

Hernani Robin is an author at University of Glasgow specializing in pharmacology, pharmacokinetic parameters, and pharmacokinetics of cytotoxic chemotherapy.

Publications per year

1997–1997

Publications

Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.

Suresh Senan, R Rampling, Marien Alet Graham et al. · PubMed · 1997 · 48 citations

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial

Martin A. Graham, Suresh Senan, Hernani Robin et al. · Cancer Chemotherapy and Pharmacology · 1997 · 38 citations

Medicine, Pharmacokinetics, Pharmacology +15

1–2 of 2